China NMPA Product Recall - Lumbar external drainage and monitoring system

On December 21, 2020, the National Medical Products Administration (NMPA) issued an announcement regarding a voluntary Class III recall initiated by Medtronic Inc. and reported by Medtronic (Shanghai) Management Co., Ltd. The recall pertains to specific models and batches of Medtronic's Lumbar External Drainage and Monitoring System, identified by Registration Certificate No.: 20173660162. The core issue leading to this action was the distribution and sale of these medical devices in Singapore and South Korea without obtaining the necessary local regulatory approvals in those countries. This oversight in complying with regional market authorization requirements prompted Medtronic Inc. to proactively address the non-compliance. As a corrective measure, Medtronic Inc. is undertaking a voluntary Class III recall of the affected products. This action is crucial for withdrawing devices from markets where they were distributed without proper local clearance, thereby upholding regulatory standards. Comprehensive details concerning the specific models, specifications, and batch numbers impacted by this recall are provided in the accompanying "Medical Device Recall Event Report Form." This event highlights the critical necessity for companies to adhere strictly to country-specific regulatory frameworks for medical device distribution globally.